You are here: Industry Insights > antibody

News List

IRBM Signs Agreement with MD Anderson Cancer Center contractpharma
September 12, 2019
IRBM has signed a service and development agreement with The University of Texas MD Anderson Cancer Center.
Antibody Drug Conjugates Market to Be Worth $15bn by 2030 europeanpharmaceuticalreview
September 02, 2019
Antibody drug conjugates are presently recognised as a potent class of targeted anticancer therapies which will result in growth in the market.
Velabs Therapeutics Enters into a Screening Cooperation with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening After b3cnewswire
August 30, 2019
Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, today announced that its cooperation with Chiome Bioscience, Inc., Tokyo, will be deepened...
Alligator Bioscience signs antibody agreement for Greater China biospectrumasia
August 22, 2019
Alligator has granted Biotheus rights in Greater China to an antibody from ALLIGATOR-GOLD® for the creation of up to three bispecific molecules.
FDA antibody biosimilar product approvals increase in 2019 europeanpharmaceuticalreview
August 12, 2019
2019 has seen a marked increase of antibody biosimilar product approvals in the first half of the year, according to a report.
IONTAS, Teva Enter Antibody Optimization Agreement contractpharma
July 30, 2019
Partnership includes options for the screening of biophysical properties suitable for developable antibodies.
Celgene licenses antibody JTX-8064 from Jounce for $50m pharmaceutical-technology
July 25, 2019
Global biopharma company Celgene has updated its 2016 strategic collaboration with clinical stage-focused Jounce Therapeutics and has decided to license global rights to JTX-8064; Celgene will now be responsible for all development and commercialisation o
New model could be used to predict shelf life of drugs europeanpharmaceuticalreview
July 25, 2019
Researchers have developed a model that describes how antibody solutions separate into different phases and could be used to anticipate the stability and shelf-life of drugs.
Downstream processing market will grow to record $40bn by 2026 europeanpharmaceuticalreview
July 22, 2019
The global downstream processing market is predicted to witness record-breaking growth due to a surge in the adoption of biotech processes.
BeiGene’s Tislelizumab Achieves Positive Phase II Results contractpharma
July 19, 2019
Investigational anti-PD-1 antibody aims to treat Chinese patients with relapsed/refractory classical Hodgkin’s lymphoma.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page